What is the role of dopamine-receptor blocking drugs in the management of tardive dyskinesia (TD)?

Updated: Oct 17, 2018
  • Author: James Robert Brasic, MD, MPH; Chief Editor: Selim R Benbadis, MD  more...
  • Print


Movement disorders may be aggravated by the administration of dopamine-receptor blocking drugs. In vulnerable patients, the administration of even a single dose of a dopamine-receptor blocking drug may lead to incapacitating movement disorders.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!